← Leaderboards
Kit S Lam
University Of California At Davis
$32,497,491
Attributed
$36,364,792
Total exposure
33
Grants
23
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,805,612 · 34
By mechanism
R01$15,135,049 · 6
U19$7,289,423 · 3
U01$5,977,862 · 3
R33$5,284,135 · 6
R21$2,311,356 · 5
UG3$2,286,044 · 1
Top collaborators
- Luis Guillermo Carvajal Carmona6 shared
- R. Holland Cheng6 shared
- Viswanathan V Krishnan6 shared
- Yoshihiro Izumiya3 shared
- James S Trimmer3 shared
- Angela Gelli1 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- Laura Marcu$16,612,855
- Kc Kent Lloyd$119,085,810
- Angela Gelli$8,579,005
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignPeptidesLigandsCombinatorial ChemistryBaseMalignant NeoplasmsIn VivoTumorXenograft ModelNeoplastic CellLeadPharmaceutical PreparationsLibrariesIn VitroReportingCombinatorialResponseSurfaceIntegrinsGrantTechnologyLabelResearch PersonnelImage
Grant awards (156)
Accelerating the Discovery of Antifungal Peptides with OBOC Combinatorial Technology.$642,775
R56 · FY2025 · AI
Novel approach to modulate the TME on-demand with therapeutic peptides and proteins.$615,399
R01 · FY2025 · CA · contact PI
Combinatorial Chemistry and Chemical Biology Shared Resource$106,765
P30 · FY2025 · CA · contact PI
Cancer Therapeutics Program$46,274
P30 · FY2025 · CA · contact PI
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$540,560
R01 · FY2024 · CA · contact PI
Cancer Therapeutics Program$108,030
P30 · FY2024 · CA · contact PI
Bridges to Doctorate Program between Fresno State and UC Davis$57,018
T32 · FY2024 · GM
Combinatorial Chemistry and Chemical Biology Shared Resource$1
P30 · FY2024 · CA · contact PI
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$560,183
R01 · FY2023 · CA · contact PI
Bridges to Doctorate Program between Fresno State and UC Davis$273,971
T32 · FY2023 · GM
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$113,453
R01 · FY2023 · CA · contact PI
Cancer Therapeutics Program$107,953
P30 · FY2023 · CA · contact PI
Combinatorial Chemistry and Chemical Biology Shared Resource$1
P30 · FY2023 · CA · contact PI
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$562,737
R01 · FY2022 · CA · contact PI
Bridges to Doctorate Program between Fresno State and UC Davis$268,839
T32 · FY2022 · GM
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$113,454
R01 · FY2022 · CA · contact PI
Cancer Therapeutics Program$107,616
P30 · FY2022 · CA · contact PI
Combinatorial Chemistry and Chemical Biology Shared Resource$1
P30 · FY2022 · CA · contact PI
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing$784,845
UG3 · FY2021 · TR · contact PI
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$572,096
R01 · FY2021 · CA · contact PI
Bridges to Doctorate Program between Fresno State and UC Davis$323,829
T32 · FY2021 · GM
Cancer Therapeutics Program$105,929
P30 · FY2021 · CA · contact PI
A Mannose 6-Phosphate Decorated Transformable Nanoplatform for Targeted Uptake in HER2+ Tumors$71,457
R01 · FY2021 · CA · contact PI
Development of Research And Writing Skills (DRAWS): A tool for broader assessment to enhance research and research training$6,667
T32 · FY2021 · GM
Combinatorial Chemistry and Chemical Biology Shared Resource$1
P30 · FY2021 · CA · contact PI
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing$765,041
UG3 · FY2020 · TR · contact PI
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers$573,341
R01 · FY2020 · CA · contact PI
Bridges to Doctorate Program between Fresno State and UC Davis$123,576
T32 · FY2020 · GM
Combinatorial Chemistry$107,570
P30 · FY2020 · CA · contact PI
Cancer Therapeutics Program$29,124
P30 · FY2020 · CA · contact PI
Cell-specific nanocarrier with endocytic and endosomolytic activities for therapeutic genome editing$736,158
UG3 · FY2019 · TR · contact PI
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics$563,282
U01 · FY2019 · CA · contact PI
Targeting nanotherapeutics against murine and feline oral cancer$518,074
R01 · FY2019 · EB · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$334,535
R01 · FY2019 · CA · contact PI
Combinatorial Chemistry$103,998
P30 · FY2019 · CA · contact PI
Cancer Therapeutics Program$29,124
P30 · FY2019 · CA · contact PI
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics$586,386
U01 · FY2018 · CA · contact PI
Targeting nanotherapeutics against murine and feline oral cancer$527,874
R01 · FY2018 · EB · contact PI
GESI: a novel technology for functional imaging in living cells$360,046
R33 · FY2018 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$345,281
R01 · FY2018 · CA · contact PI
Combinatorial Chemistry$94,168
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$21,178
P30 · FY2018 · CA · contact PI
Combinatorial Chemistry$12,500
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$12,499
P30 · FY2018 · CA · contact PI
Combinatorial Chemistry$11,775
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$11,775
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$10,000
P30 · FY2018 · CA · contact PI
Combinatorial Chemistry$10,000
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$6,250
P30 · FY2018 · CA · contact PI
Combinatorial Chemistry$6,250
P30 · FY2018 · CA · contact PI
Combinatorial Chemistry$4,474
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$4,474
P30 · FY2018 · CA · contact PI
Combinatorial Chemistry$3,000
P30 · FY2018 · CA · contact PI
Cancer Therapeutics Program$2,999
P30 · FY2018 · CA · contact PI
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics$586,386
U01 · FY2017 · CA · contact PI
Targeting nanotherapeutics against murine and feline oral cancer$524,445
R01 · FY2017 · EB · contact PI
GESI: a novel technology for functional imaging in living cells$371,314
R33 · FY2017 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$345,660
R01 · FY2017 · CA · contact PI
Genetically Encoded Small Illuminants for 4D nucleome imaging$330,000
U01 · FY2017 · EB · contact PI
Combinatorial Chemistry$103,779
P30 · FY2017 · CA · contact PI
Cancer Therapeutics Program$29,125
P30 · FY2017 · CA · contact PI
Genetically encoded reporters of integrated neural activity for functional mapping of neural circuitry$682,482
U01 · FY2016 · NS · contact PI
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics$586,386
U01 · FY2016 · CA · contact PI
Targeting nanotherapeutics against murine and feline oral cancer$462,903
R01 · FY2016 · EB · contact PI
GESI: a novel technology for functional imaging in living cells$362,749
R33 · FY2016 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$337,307
R01 · FY2016 · CA · contact PI
Genetically Encoded Small Illuminants for 4D nucleome imaging$330,000
U01 · FY2016 · EB · contact PI
Combinatorial Chemistry$102,989
P30 · FY2016 · CA · contact PI
Cancer Therapeutics Program$29,125
P30 · FY2016 · CA · contact PI
Genetically encoded reporters of integrated neural activity for functional mapping of neural circuitry$695,956
U01 · FY2015 · NS · contact PI
The rodent eye as a non-invasive window for understanding cancer nanotherapeutics$584,839
U01 · FY2015 · CA · contact PI
Genetically Encoded Small Illuminants for 4D nucleome imaging$330,000
U01 · FY2015 · EB · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$305,863
R01 · FY2015 · CA · contact PI
Genetically encoded reporters of integrated neural activity for functional mapping of neural circuitry$702,145
U01 · FY2014 · NS · contact PI
Multi-functional Nanocarrier against Canine Lymphoma$499,245
R01 · FY2014 · EB · contact PI
Discovery of Death Ligands Against Cancers$326,817
R33 · FY2014 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$281,879
R01 · FY2014 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$51,944
R01 · FY2014 · CA · contact PI
Multi-functional Nanocarrier against Canine Lymphoma$501,309
R01 · FY2013 · EB · contact PI
Discovery of Death Ligands Against Cancers$329,662
R33 · FY2013 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$279,713
R01 · FY2013 · CA · contact PI
Discovery of ligands for directed-differentiation of stem cells$219,912
R21 · FY2013 · HL · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$47,539
R01 · FY2013 · CA · contact PI
Multi-functional Nanocarrier against Canine Lymphoma$596,201
R01 · FY2012 · EB · contact PI
Discovery of Death Ligands Against Cancers$353,500
R33 · FY2012 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$310,460
R01 · FY2012 · CA · contact PI
Discovery of ligands for directed-differentiation of stem cells$192,136
R21 · FY2012 · HL · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$77,226
R01 · FY2012 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$38,683
R01 · FY2012 · CA · contact PI
Multi-functional Nanocarrier against Canine Lymphoma$547,918
R01 · FY2011 · EB · contact PI
High affinity capturing agents for strychnine$367,407
R21 · FY2011 · NS · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$299,038
R01 · FY2011 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$58,992
R01 · FY2011 · CA · contact PI
FEASIBILITY OF NANOPARTICLE-MEDIATED PACLITAXEL DELIVERY$46,810
P41 · FY2011 · RR · contact PI
Multi-functional Nanocarrier against Canine Lymphoma$26,827
R01 · FY2011 · EB · contact PI
High affinity capturing agents for strychnine$362,200
R21 · FY2010 · NS · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$302,871
R01 · FY2010 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$47,903
R01 · FY2010 · CA · contact PI
FEASIBILITY OF NANOPARTICLE-MEDIATED PACLITAXEL DELIVERY$16,992
P41 · FY2010 · RR · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$10,070
R01 · FY2010 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$8,892
R01 · FY2010 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$1,052,902
U19 · FY2009 · CA · contact PI
Optimization and Characterization of Targeting Agents for Lymphoid Malignancies$410,075
U19 · FY2009 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$299,843
R01 · FY2009 · CA · contact PI
DNA-modulated release of drug from melanoma targeting NP$205,200
R21 · FY2009 · CA · contact PI
High affinity ligand to deliver nanoparticle drugs to lymphoid cancers$152,000
R21 · FY2009 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$60,652
U19 · FY2009 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$60,652
R01 · FY2009 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$1,031,038
U19 · FY2008 · CA · contact PI
Optimization and Characterization of Targeting Agents for Lymphoid Malignancies$410,842
U19 · FY2008 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$301,109
R01 · FY2008 · CA · contact PI
DNA-modulated release of drug from melanoma targeting NP$171,000
R21 · FY2008 · CA · contact PI
High affinity ligand to deliver nanoparticle drugs to lymphoid cancers$152,000
R21 · FY2008 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$59,963
R01 · FY2008 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$59,963
U19 · FY2008 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$1,049,786
U19 · FY2007 · CA · contact PI
Optimization and Characterization of Targeting Agents for Lymphoid Malignancies$424,174
U19 · FY2007 · CA · contact PI
c-src inhibitors from novel encoded chemical libraries$311,244
R01 · FY2007 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$309,920
R01 · FY2007 · CA · contact PI
High affinity ligand to deliver nanoparticle drugs to lymphoid cancers$152,000
R21 · FY2007 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$135,561
R01 · FY2007 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$50,652
R01 · FY2007 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$46,332
U19 · FY2007 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$1,063,877
U19 · FY2006 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$319,915
R01 · FY2006 · CA · contact PI
c-src inhibitors from novel encoded chemical libraries$314,639
R01 · FY2006 · CA · contact PI
Optimization and Characterization of Targeting Agents$277,267
U19 · FY2006 · CA · contact PI
Therapeutic Targeting Agents for Ovarian Cancer$135,152
R01 · FY2006 · CA · contact PI
Combinatorial Peptide Libraries for Biodegradable Linkers to Decrease Normal Tiss$121,924
P01 · FY2006 · CA · contact PI
Targeting Agents for Human and Canine Lymphoma$1,076,270
U19 · FY2005 · CA
Small molecule microarrays for intracellular proteins$359,320
R33 · FY2005 · CA
Therapeutic Targeting Agents for Ovarian Cancer$328,902
R01 · FY2005 · CA
c-src inhibitors from novel encoded chemical libraries$321,780
R01 · FY2005 · CA
Optimization and Characterization of Targeting Agents$275,600
U19 · FY2005 · CA
Protein kinase specific PET imaging agent for cancer$170,438
R21 · FY2005 · CA
Combinatorial Peptide Libraries for Biodegradable Linkers to Decrease Normal Tiss$118,373
P01 · FY2005 · CA
Administrative Core$50,645
U19 · FY2005 · CA
Small molecule microarrays for intracellular proteins$358,504
R33 · FY2004 · CA
c-src inhibitors from novel encoded chemical libraries$319,405
R01 · FY2004 · CA
Protein kinase specific PET imaging agent for cancer$167,063
R21 · FY2004 · CA
Combinatorial Peptide Libraries for Biodegradable Linkers to Decrease Normal Tiss$117,972
P01 · FY2004 · CA
UC Davis AP4 Center$74,250
U56 · FY2004 · CA
PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS$456,335
R33 · FY2003 · EB
Small molecule microarrays for intracellular proteins$359,003
R33 · FY2003 · CA
c-src inhibitors from novel encoded chemical libraries$315,736
R01 · FY2003 · CA
PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS$316,485
R33 · FY2002 · CA
LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER$242,961
R33 · FY2002 · CA
LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER$67,083
R33 · FY2002 · CA
PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS$65,242
R33 · FY2002 · CA
PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS$326,516
R33 · FY2001 · CA
LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER$240,278
R33 · FY2001 · CA
LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER$65,130
R33 · FY2001 · CA
PEPTIDE MICROARRAY FOR CANCER CELL SURFACE RECEPTORS$42,182
R33 · FY2001 · CA
LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER$27,652
R33 · FY2001 · CA
LIGANDS FOR ALTERED PHOSPHOPROTEINS IN CANCER$253,356
R33 · FY2000 · CA
PEPTIDE SUBSTRATE FOR UNIQUE PROTEIN KINASE IN TISSUE$139,244
R01 · FY2000 · CA